| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |